Rwanda’s drug regulator has recalled a batch of Johnson & Johnson children’s cough syrup due to concerns about its safety.
This move comes after Nigeria discovered high levels of toxicity in laboratory tests.
The syrup, which is used to treat coughs and allergies in children, has also been recalled in Kenya and South Africa, with another batch being recalled in South Africa.
The recalled batch was manufactured by J&J in South Africa in May 2021, but it is now owned by Kenvue, which spun off from J&J last year.
Rwanda’s drug regulator has recalled a batch of Johnson & Johnson children’s cough syrup due to concerns about its safety.
This move comes after Nigeria discovered high levels of toxicity in laboratory tests.
The syrup, which is used to treat coughs and allergies in children, has also been recalled in Kenya and South Africa, with another batch being recalled in South Africa.
The recalled batch was manufactured by J&J in South Africa in May 2021, but it is now owned by Kenvue, which spun off from J&J last year.
The Rwanda Food and Drugs Authority stated that, while no adverse events have been reported, the recall is a precautionary measure.
Laboratory tests conducted by Nigeria’s health regulator revealed high levels of diethylene glycol, a substance associated with child deaths in other countries since 2022.
Kenvue stated that it is conducting its own assessment and working with health authorities to determine next steps.
